Grufity logoGrufity logo

EVH

28.79USD+1.80(+6.67%)Market Closed

Evolent Health Inc

Market Summary

USD28.79+1.80Market Closed
6.67%

EVH Alerts

EVH Stock Price

RSI Chart

Valuation

Market Cap

2.9B

Price/Earnings

-102.89

Price/Sales

2.71

Price/Cashflow

43.71

MarketCap/EBT

-157.82

Price/Sales

Profitability

EBT Margin

-1.72%

Return on Equity

-4.67%

Return on Assets

-2.2%

Fundamentals

Revenue

Revenue (TTM)

1.1B

Revenue Y/Y

44.08%

Revenue Q/Q

7.7%

Earnings

Earnings (TTM)

-28.6M

Earnings Y/Y

49.62%

Earnings Q/Q

14.24%

Price Action

52 Week Range

21.3639.78
(Low)(High)

Last 7 days

4.0%

Last 30 days

-9.5%

Last 90 days

-22.1%

Trailing 12 Months

10.7%

Financial Health

Current Ratio

1.23

Debt/Equity

0.41

Debt/Cashflow

0.14

Investor Care

Shares Dilution (1Y)

5.04%

Diluted EPS (TTM)

-0.33

Peers (Alternatives to Evolent Health)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
515.6B
315.1B
-1.33% 24.91%
28.25
1.68
12.82% 25.96%
123.7B
315.2B
7.58% 16.98%
15.14
0.4
10.58% -58.39%
27.9B
5.8B
0.98% 20.75%
47.36
4.81
5.93% -26.79%
26.5B
2.0B
13.35% -32.64%
67.34
13.25
20.29% -7.22%
MID-CAP
9.0B
3.5B
11.88% 31.28%
-117.28
2.58
7.15% -34.72%
6.5B
1.5B
-7.53% -10.06%
64.74
4.3
17.39% -19.17%
4.8B
2.3B
-3.81% -71.84%
-0.48
2.14
24.79% -1114.68%
4.1B
1.4B
-4.39% -9.54%
15.46
2.89
-20.57% -11.91%
2.9B
1.1B
-9.49% 10.73%
-102.89
2.71
17.83% 59.62%
SMALL-CAP
1.5B
245.2M
1.83% -51.77%
-8.12
5.99
36.52% -260.24%
1.3B
613.7M
3.79% 34.19%
65.1
2.15
5.58% 602.90%
862.9M
53.9M
-2.19% -13.45%
69.12
16.01
16.01% 27.61%
500.7M
271.8M
18.82% -75.85%
-3.46
1.89
17.92% -2.29%
278.8M
63.1M
36.81% -67.55%
-39.93
4.35
9.93% -1043.45%
94.0M
302.5M
14.80% -60.42%
-0.81
0.3
-0.73% -57.66%

Financials for Evolent Health

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Revenue9.9%1,088990908906923
Operating Expenses7.2%1,0199509661,015
  S&GA Expenses7.4%236220219202203
  R&D Expenses-16
Earnings Before Taxes20.1%-18.66-23.37-29.80-42.27-66.00
Net Income13.6%-28.62-33.14-37.60-46.58-70.89
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Assets-2.6%1,3041,3391,4191,2541,293
  Current Assets-8.7%423463524478506
    Cash Equivalents-8.1%193210266252207
  Net PPE11.8%9383818283
  Goodwill0.0%426426426349349
Liabilities-5.1%691728726646679
  Current Liabilities-10.4%343382445367403
    LT Debt, Current-100.0%-2727--
    LT Debt, Non Current0.2%283283216211207
Shareholder's Equity0.3%613611694607614
  Retained Earnings-0.8%-596.93-592.34-626.78-621.13-608.09
  Additional Paid-In Capital0.6%1,2311,2241,3411,2491,243
Shares Outstanding0.6%90908685-
Float-1,600----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Cashflow From Operations128.7%672939-40.76-105.76
  Share Based Compensation18.3%2218171615
Cashflow From Investing-24.2%-55.84-44.97-15.7936320
Cashflow From Financing221.8%31-25.34-29.55-114.36-128.86

Risks

What is the probability of a big loss on EVH?

95.8%


Probability that Evolent Health stock will be more than 20% underwater in next one year

83.5%


Probability that Evolent Health stock will be more than 30% underwater in next one year.

53.9%


Probability that Evolent Health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does EVH drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Evolent Health was unfortunately bought at previous high price.

Returns

Cumulative Returns on EVH

7.8%


7-Year Cumulative Returns

17.5%


5-Year Cumulative Returns

58.7%


3-Year Cumulative Returns

What are the long-term rolling returns for EVH?

FIve years rolling returns for Evolent Health.

Which funds bought or sold EVH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-1.46
473,000
3,570,000
0.01%
2022-11-17
CENTRAL TRUST Co
UNCHANGED
-
3,000
26,000
-%
2022-11-16
GLENMEDE TRUST CO NA
REDUCED
-34.74
-6,018,000
19,423,000
0.12%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-54,000
-
-%
2022-11-15
STATE STREET CORP
ADDED
2.47
10,312,000
62,162,000
-%
2022-11-15
JANE STREET GROUP, LLC
REDUCED
-10.22
75,000
1,567,000
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
HARBOUR INVESTMENTS, INC.
UNCHANGED
-
-
450,000
0.03%
2022-11-15
BNP PARIBAS ARBITRAGE, SNC
ADDED
654.29
5,286,710
5,962,330
0.01%
2022-11-15
CIBC Private Wealth Group, LLC
UNCHANGED
-
35,000
241,000
-%

1–10 of 42

Latest Funds Activity

Are funds buying EVH calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own EVH

Evolent Health News

StockNews.com

LOW: 3 Stocks You'll Be Thankful You Own This Winter.19 hours ago

EVH Fair Value

Recent SEC filings of Evolent Health

View All Filings
Date Filed Form Type Document
Nov 23, 2022
4
Insider Trading
Nov 17, 2022
8-K
Current Report
Nov 10, 2022
8-K
Current Report
Nov 03, 2022
10-Q
Quarterly Report
Nov 03, 2022
4
Insider Trading
Nov 02, 2022
8-K
Current Report
Oct 11, 2022
8-K
Current Report
Sep 26, 2022
3
Insider Trading
Sep 06, 2022
8-K
Current Report
Sep 01, 2022
4
Insider Trading

Latest Insider Trading transactions for EVH

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-21
Blackley Seth
ACQUIRED
288,000
3.84
75,000
Chief Executive Officer
2022-11-21
Blackley Seth
SOLD
-2,009,250
26.79
-75,000
Chief Executive Officer
2022-11-01
WILLIAMS FRANK J
SOLD
-3,225,360
29.3215
-110,000
-
2022-11-01
WILLIAMS FRANK J
ACQUIRED
422,400
3.84
110,000
-
2022-08-31
Scott Cheryl
SOLD
-113,956
36.76
-3,100
-
2022-08-24
WILLIAMS FRANK J
ACQUIRED
697,500
13.95
50,000
-
2022-08-24
WILLIAMS FRANK J
SOLD
-1,860,500
37.21
-50,000
-
2022-08-23
WILLIAMS FRANK J
SOLD
-5,362,500
35.75
-150,000
-
2022-08-23
WILLIAMS FRANK J
ACQUIRED
576,000
3.84
150,000
-
2022-08-17
Johnson John Paul
SOLD
-628,784
34.11
-18,434
Chief Financial Officer

1–10 of 50

EVH Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenue[1]$ 352,585$ 222,471$ 969,581$ 659,599
Expenses    
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below)[1]266,617163,126736,061493,071
Selling, general and administrative expenses[1]68,52151,292186,408152,582
Depreciation and amortization expenses17,19614,85947,41444,962
Change in fair value of contingent consideration(12,700)(225)(5,822)(819)
Total operating expenses339,634229,052964,061689,796
Operating income (loss)12,951(6,581)5,520(30,197)
Interest income425120765311
Interest expense(4,754)(6,367)(9,143)(18,978)
Gain from equity method investees1,392633,94012,725
Gain on transfer of membership00022,969
Loss on extinguishment/repayment of debt(10,192)0(10,192)(19,158)
Change in tax receivable agreement liability(42,870)0(42,870)0
Other income (expense), net(345)(41)130(73)
Loss from continuing operations before income taxes(43,393)(12,806)(51,850)(32,401)
Provision for (benefit from) income taxes(45,516)234(44,498)936
Income (loss) from continuing operations2,123(13,040)(7,352)(33,337)
Income (loss) from discontinued operations, net of tax[2]00(463)1,383
Net income (loss) attributable to common shareholders of Evolent Health, Inc.2,123(13,040)(7,815)(31,954)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted$ 2,123$ (13,040)$ (7,815)$ (31,954)
Basic:    
Continuing operations (in dollars per share)$ 0.02$ (0.15)$ (0.08)$ (0.39)
Discontinued operations (in dollars per share)00(0.01)0.02
Basic income (loss) per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share)0.02(0.15)(0.09)(0.37)
Diluted:    
Continuing operations (in dollars per share)0.02(0.15)(0.08)(0.39)
Discontinued operations (in dollars per share)00(0.01)0.02
Diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share)$ 0.02$ (0.15)$ (0.09)$ (0.37)
Weighted-average common shares outstanding    
Basic (in shares)95,28685,80091,64385,306
Diluted (in shares)99,30885,80091,64385,306
Comprehensive income (loss)    
Net income (loss)$ 2,123$ (13,040)$ (7,815)$ (31,954)
Other comprehensive income (loss), net of taxes, related to:    
Foreign currency translation adjustment(262)4(682)(85)
Total comprehensive income (loss) attributable to common shareholders of Evolent Health, Inc.$ 1,861$ (13,036)$ (8,497)$ (32,039)
[1]See Note 18 for amounts attributable to unconsolidated related parties included in these line items.
[2]Includes $(0.5) million loss on disposal of discontinued operations for the nine months ended September 30, 2022 and $1.9 million gain on disposal of discontinued operations for the nine months ended September 30, 2021, respectively

EVH Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 156,756$ 266,280
Restricted cash and restricted investments25,05775,685
Accounts receivable, net[1]187,633130,604
Prepaid expenses and other current assets[1]24,32851,391
Total current assets393,774523,960
Restricted cash and restricted investments13,00512,977
Investments in equity method investees5,2225,458
Property and equipment, net94,64581,365
Right-of-use assets - operating50,69650,203
Prepaid expenses and other noncurrent assets[1]3,0646,790
Contract cost assets24,58832,624
Intangible assets, net451,398279,784
Goodwill722,790426,297
Total assets1,759,1821,419,458
Current liabilities:  
Accounts payable[1]61,86396,084
Accrued liabilities[1]132,238107,241
Operating lease liability - current7,0537,069
Accrued compensation and employee benefits37,64651,861
Deferred revenue7,52411,944
Reserve for claims and performance-based arrangements[1]135,698171,294
Total current liabilities382,022445,493
Long-term debt, net412,444215,676
Other long-term liabilities4,2605,531
Tax receivable agreement liability42,8700
Operating lease liabilities - noncurrent57,84057,722
Deferred tax liabilities, net3,6081,403
Total liabilities903,044725,825
Commitments and Contingencies (See Note $11)
Shareholders' Equity  
Class A common stock - $0.01 par value; 750,000,000 shares authorized; 101,159,072 and 90,758,318 shares issued, respectively1,012908
Additional paid-in-capital1,472,0981,340,989
Accumulated other comprehensive loss(1,044)(362)
Retained earnings (accumulated deficit)(594,805)(626,779)
Treasury stock, at cost; 1,537,582 shares issued, respectively(21,123)(21,123)
Total shareholders' equity856,138693,633
Total liabilities and shareholders' equity$ 1,759,182$ 1,419,458
[1]See Note 18 for amounts attributable to related parties included in these line items.